PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

MENLO PARK, Calif., Feb. 15, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2023. Fourth quarter results Revenue of $58.4 million, a 113% increase compared with $27.4 million in the prior-year period….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks